10-Q: Flora Growth Pivots to AI Treasury, Divests Cannabis

Flora Growth Corp. is rebranding as ZeroStack, pivoting to a decentralized AI treasury strategy with significant 0G Token investments while divesting its legacy hemp and cannabis operations.

Summary

• Flora Growth Corp. is undergoing a strategic transformation, rebranding as ZeroStack and shifting its primary focus to a decentralized AI treasury strategy, centered on investments in 0G Tokens.
• The company divested its entire legacy hemp and cannabis business on September 26, 2025, in exchange for the cancellation of approximately $2.2 million in promissory notes.
• Significant capital raises occurred, including $13.3 million in cash from the first closing of a PIPE Offering and $54.7 million in 0G Tokens in exchange for PIPE Pre-Funded Warrants.
• Total assets increased substantially to $74.01 million as of September 30, 2025, from $26.23 million at December 31, 2024, primarily due to the acquisition of digital assets totaling $55.4 million.
• Shareholders' equity saw a massive increase to $64.92 million from $4.51 million over the same period.
• The company reported a net loss of $9.83 million for the nine months ended September 30, 2025, consistent with the prior year, with continuing operations showing a net loss of $5.51 million.
• Cash and restricted cash increased to $13.13 million at September 30, 2025, from $5.25 million at December 31, 2024.
• Management changes occurred on October 1, 2025, with Daniel Reis-Faria appointed CEO and Michael Heinrich appointed Executive Chairman, following the resignations of Clifford Starke and Sammy Dorf.
• The company regained compliance with Nasdaq's minimum bid price requirement after a 1-for-39 reverse stock split on August 4, 2025, but is non-compliant with independent director and audit committee requirements due to a director's passing.

Sentiment

Score: 6

Explanation: The company is undergoing a significant strategic transformation, moving into the high-growth digital asset and AI infrastructure space, which is a positive long-term directional shift. This pivot is backed by substantial capital raises and a significant increase in digital assets on the balance sheet. However, current operating losses persist, cash burn has increased, and there are immediate corporate governance compliance issues with Nasdaq. The inherent volatility and regulatory uncertainty of the cryptocurrency market also introduce considerable risk.

Positives

• Successfully pivoted to a new digital asset treasury strategy, acquiring $55.4 million in digital assets (primarily 0G Tokens).
• Significant capital infusion through PIPE offerings, raising $13.3 million in cash and $54.7 million in 0G Tokens.
• Substantial increase in total assets to $74.01 million and shareholders' equity to $64.92 million.
• Divestment of the legacy hemp and cannabis business, streamlining operations and eliminating $2.2 million in promissory notes.
• Regained compliance with Nasdaq's minimum bid price requirement.
• Believes existing cash and digital assets are sufficient for short and long-term working capital and future obligations.
• Reported a $1.16 million gain on the deconsolidation of insolvent subsidiaries.
• Realized gains on dispositions of digital assets of $0.575 million for the nine months ended September 30, 2025.
• Unrealized gains from changes in fair value of digital assets of $0.732 million for the nine months ended September 30, 2025 (Note 7 indicates this specific gain, though the consolidated statement shows a net unrealized loss from all financial instruments).

Negatives

• Continued net loss of $9.83 million for the nine months ended September 30, 2025, and an accumulated deficit of $167.88 million.
• Increased cash used in operating activities, rising to $5.52 million for the nine months ended September 30, 2025, from $3.69 million in the prior year.
• Gross profit decreased to $1.49 million (6% gross margin) for the nine months ended September 30, 2025, from $1.91 million (7% gross margin) in the prior year, primarily due to decreased margins at the Phatebo subsidiary.
• Non-compliance with Nasdaq's corporate governance requirements regarding independent directors and audit committee composition.
• Incurred a $0.6 million contingency loss for a legal proceeding related to a former subsidiary (Vessel Brand Inc.).
• Settled a legal dispute related to the Just Brands LLC acquisition for $1.8 million cash, which was $1.4 million higher than the prior estimate.
• Unrealized loss from changes in fair value of financial instruments of $0.158 million for the nine months ended September 30, 2025 (consolidated statement).

Risks

• High volatility in the market price of 0G Tokens and other digital assets held by the company.
• The possibility that Cryptocurrencies (excluding Solana) may be classified as 'securities' by regulators, potentially subjecting the company to additional regulation under the Investment Company Act of 1940.
• Decrease in liquidity of 0G Tokens or any other digital assets held.
• Damage to the company's reputation due to negative publicity.
• Exposure to product liability claims, actions, and litigation, and risks associated with product recalls (from remaining pharmaceutical business).
• Challenges in successfully integrating acquired businesses.
• Inability to fund overhead expenses, including costs associated with being a publicly-listed company.
• Changes to energy prices and supply, which could impact digital asset validating operations.
• Regulatory compliance risks, including potential delisting if corporate governance issues are not resolved.
• Concentration of 0G holdings limits risk mitigation compared to a diversified portfolio.
• Historical financial statements do not reflect the potential variability in earnings from significant 0G holdings due to fair value accounting.
• Risks of disruption or unanticipated difficulties in the peer-to-peer networks of Cryptocurrencies.
• Custody risks, including loss or destruction of private keys, cyberattacks, smart contract vulnerabilities, and potential treatment as a general unsecured creditor in custodian insolvency.
• Enhanced regulatory oversight due to the 0G treasury strategy, including anti-money laundering (AML) and sanctions compliance.
• Competition from other digital assets, blockchains, and decentralized finance platforms.
• 0G Tokens are newly minted and supported by fewer trading platforms, potentially impacting liquidity.
• Potential for new AI regulations that the decentralized 0G Blockchain may be unable to comply with.
• Risks related to the sale of the legacy hemp and cannabis business, including indemnification claims and failure to realize anticipated benefits.
• Difficulties due to changes in management, as new executive officers lack prior public company executive experience.
• Potential 'passive foreign investment company' (PFIC) status for U.S. investors, leading to adverse tax consequences.
• Increased costs for director and officer liability insurance or inability to obtain coverage due to crypto asset strategy.

Future Outlook

The company intends to use proceeds from recent capital raises to further its new digital asset treasury strategy linked to 0G Tokens and to explore and expand the use of the native AI functionality of the 0G Tokens to enhance its business. The balance of net proceeds will be used for general corporate and working capital purposes. The company believes its existing cash and digital assets are sufficient for both short and long-term working capital requirements and future obligations.

Management Comments

• "The Company, which will be rebranded as ZeroStack, is a decentralized AI treasury company that is investing in the future of AI infrastructure through strategic ownership in 0G Tokens..."
• "The Company intends to use the net proceeds from the PIPE Offering and the Zero Gravity Convertible Note (collectively, the 'Cryptocurrency Offering') to further the Company's new digital asset treasury strategy linked to $0G... and to explore and expand the use of the native AI functionality of the 0G Tokens to enhance the business of the Company and the balance of the net proceeds will be used for general corporate and working capital purposes."
• "With the first closing of the PIPE Offering on September 26, 2025, as well as the closings of the PIPE Offering subsequent to September 30, 2025, the Company believes that its existing cash and digital assets are and will be sufficient in both the short and long term to meet our working capital requirements and future obligations."
• "We are committed to attaining a level of sustained growth that will effectively offset our overhead costs, thereby paving the path to achieving profitability."

Industry Context

Flora Growth's strategic pivot to a decentralized AI treasury company, rebranding as ZeroStack, positions it at the intersection of the rapidly evolving digital asset and artificial intelligence sectors. This move aligns with broader industry trends seeing increased investment in blockchain-based AI infrastructure, aiming to capitalize on the growth of decentralized AI applications. The divestment of its legacy hemp and cannabis business reflects a shift away from a highly regulated and often volatile consumer goods market towards a more technology-centric, high-growth potential area. The focus on 0G Tokens, a layer-1 blockchain for AI, indicates an ambition to become a foundational player in this emerging niche, differentiating itself from traditional cannabis or pharmaceutical companies.

Comparison to Industry Standards

• The company's shift to a digital asset treasury model, particularly with a focus on AI infrastructure tokens like 0G, is a novel strategy that deviates significantly from its previous cannabis and pharmaceutical distribution business. Direct comparisons to traditional industry benchmarks are therefore limited.
• In the broader digital asset space, companies like MicroStrategy have adopted Bitcoin treasury strategies, but Flora's focus on a specific AI-centric token (0G) and its intention to 'explore and expand the use of the native AI functionality' suggests a more active, integrated approach rather than just a passive treasury.
• The pharmaceutical distribution segment (Phatebo) operates in a mature market. The reported 6% gross margin for the nine months ended September 30, 2025, is lower than the 7% in the prior year, indicating potential competitive pressures or unfavorable product mix within that segment. This margin is generally lower than what might be seen in specialized pharmaceutical manufacturing or R&D, but within a plausible range for wholesale distribution.
• The company's accumulated deficit of $167.88 million and continued net losses indicate it is still in a growth or transition phase, which is not uncommon for companies making significant strategic pivots or operating in nascent, high-investment sectors like decentralized AI.

Management Changes

Corporate Governance

Legal Proceedings

• A legal proceeding was brought against the Company and Vessel Brand Inc. (a former subsidiary) by a lessor for breach of lease and written guaranty agreements, seeking $0.6 million in unpaid rent, interest, and attorneys' fees. The company has accrued a $0.6 million liability.
• A dispute with the sellers of Just Brands LLC regarding additional share issuance and $38.0 million in claims was settled on September 18, 2025, for a cash payment of $1.8 million. The plaintiffs forfeited all share claims.
• Two actions were brought against the Company in the Ontario Superior Court of Justice on May 31, 2023, claiming entitlement to 500,000 and 1,500,000 common shares, respectively, for alleged consulting services. The company disputes these claims and believes an unfavorable settlement is remote.

Related Party Transactions

• The acquisition of United Beverage Distribution Inc. on January 30, 2025, involved promissory notes in an aggregate principal amount of $2.1 million issued to the sellers, including Clifford Starke and Sammy Dorf (directors) and Dany Vaiman (CFO). Of the $2.2 million outstanding at September 26, 2025, $1.9 million was owed to these related parties. These notes were cancelled as part of the Cannabis Business sale.
• The Equity Transfer and Debt Repayment Agreement for the sale of the Cannabis Business on September 20, 2025, involved a group of investors that included Clifford Starke and Sammy Dorf (directors) and Dany Vaiman (CFO).
• On October 9, 2025, the remaining 5,954,743 PIPE Pre-Funded Warrants were issued to Daniel Reis-Faria, the Company's Chief Executive Officer, in exchange for 50,000,000 0G Tokens.
• Michael Heinrich, the Company's Executive Chairman, is also the Chief Executive Officer of Zero Gravity Labs Inc., with whom the company entered into an arrangement to borrow 0G Tokens and later issued a Zero Gravity Convertible Note for 50,000,000 0G Tokens.

Stakeholder Impact

• Shareholders: Significant dilution from recent equity offerings and potential future conversions of warrants and convertible notes. The strategic pivot to digital assets introduces high volatility and regulatory risk, but also potential for substantial growth. The reverse stock split improved Nasdaq compliance but reduced the number of outstanding shares. Corporate governance issues could impact investor confidence.
• Employees: Management changes have occurred, with new CEO and Executive Chairman. The strategic shift implies a change in focus and potentially workforce composition.
• Customers (Pharmaceutical): The pharmaceutical distribution business through Phatebo continues, serving customers in 28 countries.
• Creditors: Promissory notes related to the United Beverage Distribution Inc. acquisition were cancelled, reducing debt. Euro credit facilities remain.
• Former Cannabis Business Stakeholders: The sale of the legacy hemp and cannabis business impacts former employees, suppliers, and customers of those subsidiaries.

Next Steps

• Regain compliance with Nasdaq's corporate governance requirements regarding independent directors and audit committee composition within the cure period (earlier of one year from August 25, 2026, or the next annual meeting).
• Further the digital asset treasury strategy linked to 0G Tokens.
• Explore and expand the use of the native AI functionality of the 0G Tokens to enhance the business.
• Utilize net proceeds from capital raises for general corporate and working capital purposes.
• Continue to operate its global pharmaceutical distribution business through Phatebo.
• Solana locked under the PIPE Note will unlock equally each month from November 2025 through January 2028.
• Shareholder approval is required for the conversion of principal and interest of the PIPE Note and Zero Gravity Convertible Note into common shares.

Key Dates

Recommendation

Flora Growth is undergoing a radical strategic transformation, pivoting from a diverse cannabis and pharmaceutical business to a specialized AI treasury company focused on 0G Tokens. This move carries both immense potential for growth in a cutting-edge sector and significant risks due to the inherent volatility and regulatory uncertainty of digital assets. While the company has successfully raised substantial capital and improved its balance sheet liquidity, it continues to report operating losses and faces immediate corporate governance challenges. The new management team, though appointed in connection with the strategic shift, lacks prior public company executive experience, adding an element of execution risk. Given the high-risk, high-reward nature of this pivot, coupled with current operational and governance issues, a 'hold' recommendation is appropriate. Investors should monitor the execution of the AI treasury strategy, resolution of governance issues, and the evolving regulatory landscape for digital assets before making further investment decisions.

Keywords

Flora Growth Corp., ZeroStack, SEC 10-Q, Quarterly Report, Financial Results, Digital Assets, Cryptocurrency, 0G Tokens, AI Infrastructure, Blockchain, Decentralized AI, Phatebo GmbH, Pharmaceutical Distribution, Cannabis Business Divestment, PIPE Offering, Capital Raise, Nasdaq Compliance, Corporate Governance, Management Change, Reverse Stock Split, Net Loss, Shareholders' Equity, Liquidity, Risk Factors, Investment Company Act, AML Compliance, Smart Contracts